(Press-News.org) Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically expressed in the heart. They found that the enzyme may prevent a stiff heart through activating the gene TPM1 in heart muscle fibers. ALPK2 is a promising new therapeutic target for the treatment of heart failure, especially heart failure with preserved ejection function (HFpEF).
The number of heart failure patients is increasing worldwide. In particular, HFpEF is a growing global concern as it is incurable, potentially fatal, and there are limited drug therapy options. HFpEF patients are characterized by a heart that fails to relax properly during the filling phase, leading to insufficient blood flow to meet the body's needs.
The process of protein phosphorylation is central to regulating various functions in the body, including how well the heart pumps blood out. The process is controlled by enzymes called protein kinases, which add a phosphate group to specific amino acids on target proteins. This modification changes the protein's structure causing changes in its activity and interactions with other molecules. Disruptions in the enzyme’s activity play a key role in hearts becoming stiff.
The group investigated the gene expression of 518 protein kinase enzymes, revealing ALPK2 as a heart-specific kinase of interest. To understand its role, they compared mice without the gene that creates the enzyme with those that had exceptionally high levels of the gene, leading to an abundance of ALPK2.
The mice with low levels showed increased weaknesses in the aging-related ability of the heart to relax and fill with blood. On the other hand, the mice with overexpression of ALPK2 had increased phosphorylation of the amino acid tropomyosin 1 (TPM1), a major regulator of heart contraction. As HFpEF patients have decreased TPM1, increased phosphorylation of TPM1 would likely have a protective effect against the disease.
“ALPK2-overexpression suppressed progression of diastolic dysfunction. In addition, it improved lung weight, which is often used as an index of heart failure,” Yoshida summarized. “HFpEF is a growing global concern due to limited drug therapy options. Currently, there are only two drugs for HFpEF: SGLT2 inhibitor and ARNI. The ALPK2/TPM1 regulatory axis may provide a unique therapeutic target for HFpEF, allowing the development of new treatment options that target ALPK2 in the future.”
END
A new therapeutic target for a lethal form of heart failure: ALPK2
2025-01-30
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Optimism can boost saving, especially for lower-income individuals
2025-01-30
WASHINGTON – Being optimistic about the future may help people save more money, and the effect appears strongest among those with lower incomes, according to research published by the American Psychological Association.
The study found that people who scored higher on measures of “dispositional optimism” -- the tendency to expect positive outcomes -- saved more money over time compared with their less optimistic peers.
The research was published in the Journal of Personality and Social Psychology.
"We often think of optimism as rose-colored glasses ...
Findings may lead to blood test to predict risk of postpartum depression
2025-01-30
Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third trimester of pregnancy, according to a new study by researchers at Weill Cornell Medicine and the University of Virginia. These molecules influence the brain’s stress response and emotional regulation.
The findings, published XX in Neuropsychopharmacology, suggest that this may provide a way to identify women at risk of PPD before ...
New insights on radical trapping in 12-phosphatetraphene uncovered
2025-01-30
Muon spin rotation (µSR) spectroscopy is a powerful technique that helps to study the behavior of materials at the atomic level. It involves using muons—subatomic particles similar to protons but with a lighter mass. When introduced into a material, muons interact with local magnetic fields, providing unique insights into the material’s structure and dynamics, especially for highly reactive species such as radicals.
In a new study, a team of researchers led by Associate Professor Shigekazu Ito, from the School of Materials and Chemical Technology, Institute of Science Tokyo, Japan, ...
Grossman wins 2025 Transatlantic Alliance Award in Endocrinology
2025-01-30
WASHINGTON—The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce Professor Ashley Grossman, F.Med.Sci., as the winner of the 2025 Transatlantic Alliance Award.
Grossman is emeritus professor of endocrinology at the University of Oxford and a senior research fellow at Green Templeton College in Oxford, U.K. He also is a consultant endocrinologist at the Royal Free London and a professor of neuroendocrinology at Queen Mary University of London in London, ...
Girish N. Nadkarni, MD, MPH, CPH, named to leadership roles in AI and Digital Health at the Icahn School of Medicine at Mount Sinai
2025-01-30
New York, NY [January 30, 2025]—Girish N. Nadkarni, MD, MPH, CPH, an accomplished physician-scientist driving advances in artificial intelligence, has been appointed Chair of the Windreich Department of Artificial Intelligence and Human Health at the Icahn School of Medicine at Mount Sinai.
The department is the first of its kind at a U.S. medical school, underscoring Mount Sinai's leadership in integrating artificial intelligence (AI) into health care. Dr. Nadkarni will also serve as Director of the Hasso Plattner ...
A hearing aid for … your nose?
2025-01-30
Kaboom! The first time most of us hear the sound of an explosion is in the movies. Encountering the sound in the real world—even at a distance—has a profoundly different effect. Why? It’s all about context. How we react to sounds and other sensory stimuli depends on how they’re presented. We often don’t know how we’ll respond to something until we experience it. And the sensation is sometimes quite different from what we expected. So, the brain has to adjust quickly.
Cold Spring Harbor Laboratory (CSHL) Professor Florin Albeanu explains: “In ...
Borrowing nature’s blueprint: How scientists replicated bone marrow
2025-01-30
Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to immune-boosting white cells. This vital function is often disrupted in cancer patients undergoing chemotherapy or radiation, which can damage the marrow and lead to dangerously low white cell counts, leaving patients vulnerable to infection.
Now, researchers at the University of Pennsylvania School of Engineering and Applied Science (Penn Engineering), Perelman School of Medicine (PSOM) and the Children’s Hospital of Philadelphia (CHOP) have developed a platform that emulates human marrow’s ...
Politically connected corporations received more exemptions from US tariffs on Chinese imports, study finds
2025-01-30
Research recently published in The Journal of Financial and Quantitative Analysis reveals that politically connected companies were significantly more likely to receive valuable exemptions from the tariffs imposed on U.S. imports from China during the Trump administration.
The authors, Veljko Fotak (SUNY Buffalo), Grace Lee (Fordham University), William Megginson (University of Oklahoma), and Jesus Salas, associate professor of finance (Lehigh University), found that companies that made substantial investments in political connections to Republicans prior to and during the beginning of the Trump administration were ...
Walk like a … gecko? Animal footpads inspire a polymer that sticks to ice
2025-01-30
A solution to injuries from slips and falls may be found underfoot — literally. The footpads of geckos have hydrophilic (water-loving) mechanisms that allow the little animals to easily move over moist, slick surfaces. Researchers in ACS Applied Materials & Interfaces report using silicone rubber enhanced with zirconia nanoparticles to create a gecko-inspired slip-resistant polymer. They say the material, which sticks to ice, could be incorporated into shoe soles to reduce injuries in humans.
Slips ...
Role of barrier films in maintaining the stability of perovskite solar cells
2025-01-30
Perovskite solar cells (PSCs) present a revolutionary leap in renewable energy technology with their high efficiency, lightweight, and flexible nature. But their commercial applications are often hindered by their sensitivity to environmental factors like heat and humidity.
To address this, a team of researchers led by Professor Takashi Minemoto, a Ritsumeikan Advanced Research Academy Fellow from the College of Science and Engineering, Ritsumeikan University, Japan, along with Dr. Abdurashid Mavlonov from the Research Organization of Science and Technology, Ritsumeikan University, and Dr. Akinobu Hayakawa from Sekisui Chemical Co., Ltd., recently conducted pioneering ...